Clinical Endocrinology publishes papers and reviews which focus on the clinical aspects of endocrinology, including the clinical application of molecular endocrinology. It does not publish papers relating directly to diabetes care and clinical management. It features reviews, original papers, commentaries, correspondence and Clinical Questions. Clinical Endocrinology is essential reading not only for those engaged in endocrinological research but also for those involved primarily in clinical practice.

Senior Editors
J. Newell-Price, University of Sheffield, UK
Phone + 44 (0)114 2261309, Email: j.newellprice@sheffield.ac.uk
Conflict of Interest Statement
John Newell-Price is Professor of Endocrinology at the University of Sheffield. He qualified in medicine at the University of Cambridge, and undertook his clinical endocrine specialist training at St Bartholomew’s Hospital in London, where he was also an MRC Training Fellow for his PhD. Since 2000, he has been at the University of Sheffield, and Sheffield Teaching Hospitals NHS Foundation Trust where he is the Clinical Lead for the busy regional endocrine service, chairs the MDTs, and is lead for the Sheffield ENETS European Centre of Excellence for Neuroendocrine Tumours. His research interests include glucocorticoids, pituitary and neuroendocrine tumours, and has published widely in these areas.
He is Senior Editor of ‘Clinical Endocrinology’ and has served on the Editorial Board of ‘Journal of Clinical Endocrinology and Metabolism’, and on task forces for clinical guidelines authored on Cushing’s syndrome (2008 and 2015) for the Endocrine Society and Adrenal Incidentaloma (2016) for the European Society for Endocrinology. He has chaired The Royal College of Physicians, UK Joint Specialist Committee for Diabetes and Endocrinology (2012-2016), The Society for Endocrinology Clinical Update Programme (2012-2015), Medical Committee of the Pituitary Foundation (2006 to date), where he is also a trustee, and is Research Lead for the Clinical Reference Group for Specialist Endocrinology NHS England, Treasurer for the UK and Ireland Neuroendocrine Tumour Society, and is serves on the Society for Endocrinology Clinical Committee. He is Chair of the Endocrine Society’s Annual Meeting, Chicago 2018.

A. Rees, Cardiff University, Cardiff, UK
Phone: +44 (0)29 2074 2309, Email: ReesDA@cardiff.ac.uk
Conflict of Interest Statement
Aled Rees is a Professor and Consultant Endocrinologist at the School of Medicine, Cardiff University. His clinical practice embraces all aspects of endocrinology with a particular focus on neuroendocrinology and pituitary disease. Professor Rees graduated from the University of Wales College of Medicine. He was awarded a Wellcome Trust Clinical Training Fellowship and a Society for Endocrinology Clinical Endocrinology Trust Fellowship for his PhD examining growth regulation in pituitary tumours. His current research seeks to understand the impact of the hormonal environment in early life on cognition and neurodevelopment.

Editors
B. Anawalt, University of Washington, Seattle, USA
Email: BAnawalt@medicine.washington.edu
Conflict of Interest Statement
Dr. Anawalt is the Chief of Medicine at the University of Washington Medical Center and Professor and Vice Chair of the Department of Medicine at the University of Washington. He earned his bachelor’s degree in anthropology at the University of Santa Clara and his medical degree at the University of California at Davis. He completed his internal medicine residency at the University of Washington in 1992 and served as chief resident at the Seattle VA Medical Center 1992-1993. He completed a fellowship in endocrinology at the University of Washington and joined the faculty in 1995. His excellence in teaching has been recognized with the Paul Beeson Award and the Endocrinology Fellowship Teaching Award at the University of Washington. He is the North American editor for the Journal of Clinical Endocrinology and also serves on the editorial board of the Journal of Clinical Endocrinology and Metabolism. He serves as a consultant to the United States Anti-Doping Agency. He is the Chair of the Hormone Health Network, the patient education committee for the Endocrine Society. He also writes questions for the American Board of Internal Medicine Self- evaluation Program (for board re-certification). He has done NIH-funded research in male infertility, male hormonal contraception and the male reproductive physiology. He lives in Seattle with his wife and three daughters.
F. Castinetti, Aix-Marseille University, Marseille, France
E-mail: Frederic.castinetti@ap-hm.fr
Conflict of Interest Statement
Frederic Castinetti is Professor of Endocrinology at Aix-Marseille University, France. He received his Ph.D in Neuroscience from Aix-Marseille University, focusing on the roles of transcription factors in the development of combined pituitary hormone deficiencies. Dr. Castinetti did a postdoctoral fellowship at the University of Michigan with Dr. Sally Camper, where he used transgenic mouse models to investigate the roles of specific transcription factors in thyrotroph development and function. Dr. Castinetti is currently working on new etiologies of congenital hypopituitarism and the differentiation processes of stem cells into pituitary lineages in the INSERM U1251, Marseille Medical Genetics team.
In parallel, his main clinical interests are pituitary disorders especially optimal management of pituitary deficiencies, pituitary adenomas diagnosis and management, as well as adrenal disorders, either by hyper or hypofunction, or tumors. Dr Castinetti has been particularly interested in the management of hypercortisolism, the way to diagnose early recurrence of Cushing’s disease and the long-term consequences of high glucocorticoid exposure. Finally, Dr Castinetti’s recent work has been focused on the management of hereditary pheochromocytoma and medullary thyroid carcinoma, and more specifically Multiple Endocrine Neoplasia Type 2.
P.R. Ebeling, Monash University, Australia 
Email: peter.ebeling@monash.edu
Professor Peter Ebeling AO is Head, Department of Medicine, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University. He was inaugural Director of the Australian Institute of Musculoskeletal Science (AIMSS). In 2015, he was made an Officer of the General Division of the Order of Australia for distinguished service in the field of bone health.
Research interests include musculoskeletal health and diseases; public health aspects of vitamin D, including effects on muscle function, bone and diabetes; post- transplantation osteoporosis; and osteoporosis in men. Professor Ebeling was Associate Editor of Journal of Bone and Mineral Research from 2008-2012. He currently serves on the Editorial Board of Osteoporosis International and is Editor of Clinical Endocrinology (Oxf) and is Editor-in-Chief of JBMR Plus. He is Medical Director of Osteoporosis Australia; Board Member, International Osteoporosis Foundation; Past-President, Endocrine Society of Australia; Past-President of the Australian and New Zealand Bone and Mineral Society; and Councillor, American Society of Bone and Mineral Research, only the third Australian to be elected. He served on the NHMRC Research Committee from 2015-2018. He has over 360 peer-reviewed publications, including in the New England Journal of Medicine, JCI, PNAS and Science. He also supervises Research Higher Degree students and advanced physician trainees in Endocrinology.

Technical Associate Editor
F. Milat, Monash University, Australia
Medical Statisticians
P. T. Donnan, University of Dundee, Scotland
Conflict of Interest Statement
Social Media Editor
H Simpson, University College London Hospitals NHS Foundation Trust, London, UK

Editorial Board 

A. Abbara, Imperical College London, UK
R. Andrews, Exeter University, UK 
I. Banerjee, Royal Manchester Children's Hospital, UK 
M. Burt, Flinders University, Australia 
R. Casey, Cambridge University, UK
Z-J Chen, Shandong University, Beijing 
R. Crowley, St. Vincent’s University Hospital, Dublin, Ireland 
S. Davis, Monash University, Australia 
W. Dhillo, Imperial College London, UK
M. Druce, Queen Mary University of London, UK 
W. Evans, Duke University Medical Center, USA 
M. Freel, University of Glasgow, UK 
D. Führer-Sakel, University of Essen, Germany 
H. Gleeson, University Hospitals Birmingham NHS Foundation Trust, UK 
M. Grossmann, The University of Melbourne, Australia 
A. Heath, University of Oxford, UK 
M. den Heijer, Amsterdam UMC, The Netherlands
M. Hewison, The University of Birmingham, UK
C. Higham, Christie Hospital NHS Foundation Trust, UK 
B. Hollis, Medical University of South Carolina, USA 
W. Inder, Princess Alexandra Hospital, Brisbane, Australia
C. Jayasena, Imperial College London, UK 
T. Korevaar, Erasmus Medical Center, Netherlands 
D. L. Learoyd, University of Sydney, Australia
A. Leung, UCLA Medical Center, USA
P. Lips, VU University Medical Center, Netherlands 
P. Liu, Harbor UCLA Medical Center, USA 
R. Lupoli, University of Naples, Italy 
L. Maione, Hopital Bicetre, France
A. McCormack, St Vincent’s Hospital, Australia 
K. Mullan, Belfast Health & Social Care Trust, UK 
P. Newey, University of Dundee, UK
O. Okosieme, Cardiff University School of Medicine, UK 
T. Sathyapalan, Hull York Medical School, UK 
S. Senniappan, Alder Hey Children’s Hospital, Liverpool, UK 
M. Sherlock, Tallaght Hospital, Dublin, Ireland
F. Swords, Norfolk and Norwich University Hospital NHS Foundation Trust, UK